Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation.
Acta Pharm Sin B. 2021 Sep;11(9):2880-2899. doi: 10.1016/j.apsb.2021.03.011. Epub 2021 Mar 9.
Acta Pharm Sin B. 2021.
PMID: 34589402
Free PMC article.